VTI1A Antibody - N-terminal regio : FITC (ARP52812_P050-FITC)

Vesicle transport through interaction with t-SNAREs homolog 1A (yeast)

MMDS3, MVti1, VTI1RP2, Vti1-rp2

143187

Q5W0D7

NP_660207

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Pig, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human VTI1A

VTI1A is a V-SNARE that mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. VTI1A may be concerned with increased secretion of cytokines associated with cellular senescence.

UBC; env; TMBIM6; STX16; STX8; VAMP3; VAMP4; VAMP8; STX7

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Cow: 100%; Dog: 100%; Guinea Pig: 93%; Horse: 100%; Human: 100%; Mouse: 100%; Pig: 100%; Rabbit: 100%; Rat: 93%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

25kDa

Tai, G., (2004) Mol. Biol. Cell 15 (9), 4011-4022

Wet Ice

217

VTI1A

VTI1A

Rabbit

Vesicle transport through interaction with t-SNAREs homolog 1A

NM_145206

SSDFEGYEQDFAVLTAEITSKIARVPRLPPDEKKQMVANVEKQLEEAKEL